<i>BRCA1</i> Versus <i>BRCA2</i> and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?
Mark C. Markowski, Emmanuel S. Antonarakis
Topics & Concepts
MedicineProstate cancerPARP inhibitorInternal medicineOncologyProstateCancer researchCancerPoly ADP ribose polymeraseGeneticsDNAPolymeraseBiologyPARP inhibition in cancer therapyProstate Cancer Treatment and ResearchBRCA gene mutations in cancer